GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and gastrointestinal issues. Demand for weight-loss medications, including popular brands like Ozempic and Wegovy, continues to rise. A recent study revealed that one in eight Americans has used or is currently using these drugs to manage diabetes, heart […]
Source link